INNOVATORS COME FORWARD

Let’s start the life startups:

BioUpper
the innovative training & acceleration platform for startups
is back, with vouchers for € 150,000

About BioUpper

BioUpper is the first Italian training and acceleration platform to provide support for new entrepreneurial ideas in the field of life science.

Born from a partnership between Novartis and Fondazione Cariplo, in collaboration with PoliHub and with the scientific validation of Humnitas, BioUpper targets aspiring entrepreneurs with groundbreaking projects, to support them in developing their skills.

The goal of BioUpper is to enhance and reward the best ideas, in order to translate them into viable business initiatives, and thus actively contribute to the economic development of the Country.

The success of the first edition

The first edition of BioUpper has been highly successful. The credit goes to the innovative nature of the program and its ability to intercept a strong demand for support, coming from young startuppers and Italian researchers in the field of life science, who represent a dynamic and excellent reality.

The new edition

The BioUpper platform supports startuppers active on the Italian market with a tailored entrepreneurial empowerment program, providing access to the resources, facilities and relationships of the medical/scientific ecosystem.

At the end of the path, the 3 best projects receive a voucher of € 50,000 each, to access further counseling and services/activities for the development of the business idea.

To apply to the BioUpper program, send a proposal falling within one of the following areas: medical science-oriented biotechnologies, healthcare digital tools and medical devices, patient-oriented services and health delivery services.

CALL FOR IDEAS

The best business projects will access a four-stage path

01_APPLICATION SUBMISSION AND SELECTION:
INNOVATORS COME FORWARD

To participate, the application must be submitted no later than October 16, 2016, at 11.59 PM.
For the details on the eligible subjects and the project selection criteria, please refer to the Regulations.

Apply to BioUpper »
Next

02_TRAINING WEEK:
GETTING READY TO PITCH

The 20 teams selected take part in the training week, a path of frontal classes and meetings aimed at further developing the project proposal and prepare an effective pitch of the business model.

At the end of the training week, the aspiring entrepreneurs introduce their project during an elevator pitch presentation before the jury. The 10 best ideas will access the Acceleration Program.

Apply to BioUpper »
Previous Next

03_ACCELERATION PROGRAM:
HANDS-ON EXPERIENCE, MORE THAN TRAINING

The 10 projects selected by the jury access the Acceleration Program, a tailor-made path aimed at accelerating and making effective the go-to-market phase. The Acceleration Program is adjusted on each business plan, based on the life cycle of the product/service proposed, and consists of laboratory work, incubation time, continuous collaboration with the support team; the Acceleration Program develops the operativeness of the business projects selected also through an interaction with external stakeholders: tutors, business angels, consultants, university representatives, incubators.

Apply to BioUpper »
Previous Next

04_AWARD OF THE 3 BEST IDEAS:
1, 2, 3 START UP!

At the end of Acceleration Program, the 10 finalist teams will present their projects to the jury.
The latter announces the 3 best ideas, each of which will be awarded a voucher for € 50,000 (before tax), to be used for the development of the business idea.

Apply to BioUpper »
Previous

Who we are

PARTNERS

Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care and cost-saving generic pharmaceuticals. Novartis is the only global company with leading positions in all these areas. In 2015, the Group achieved net sales of USD 49.4 billion, while R&D throughout the Group amounted to approximately USD 8.9 billion (USD 8.7 billion excluding impairment and amortization charges). Novartis Group companies employ approximately 118,000 full-time-equivalent associates and operate in more than 180 Countries around the world. For more information, please visit www.novartis.it and www.novartis.com. Novartis Italy is on Twitter. Register and follow @NovartisItalia on http://twitter.com/NovartisItalia

Fondazione Cariplo has been doing philanthropic work for over twenty years, with a passion for art, culture, scientific research, social affairs and the environment. Today it is focused on supporting young people, community welfare and the wellbeing of people, implementing projects with non-profit organizations. From 1991 to date, the Foundation supported more than 30,000 initiatives, donating € 2.8 billion. In its 25 years, Cariplo managed to innovate the way of doing philanthropic work, as in the case of social housing or cultural districts. Not just a benefactor, then, but an engine of ideas.

IN COLLABORATION WITH

MAIN PARTNER LIFE SCIENCE

THE JURY

The jury is composed of experts from Corporations, Research, Finance and Institutions, active in the areas of support to entrepreneurship.

Danny Bar Zohar

Chief Scientific Officer
Novartis Farma

Henry Skinner

Venture Partner
Novartis Venture Fund

Stefano Firpo

Director General
Ministry of Economic Development

Guido Guidi

Head of Region Europe
Novartis Pharma

Giuseppe Di Piazza

Editor of Corriere Innovazione

Stefano Mainetti

Managing Director
PoliHub Fondazione Politecnico

Carlo Mango

Director Scientific Research
Fondazione Cariplo

Alberto Mantovani

Scientific Director
Istituto Clinico Humanitas

Marco Pierotti

Coordinator of Research Activities
Institute for Pediatric Research Città della Speranza
della Speranza

Diana Saraceni

Founder and Managing Partner
Panakès Partners

Roberto Scrivo

Chief Technical Secretary
Ministry of Health

Claudio Giuliano

Managing partner
Innogest

Paolo D. Siviero

Senior Advisor and Fund Manager
Principia III

Elizabeth Marie Robinson

Investment Director
Quadrivio Capital SGR,
Venture Capital Area

PARTICIPATE

Do you have an innovative idea in the field of Life Science
and you are looking for support to make it happen?

APPLY TO BIOUPPER: FILL IN THE APPLICATION FORM AND SUBMIT YOUR PROJECT.